Willie Yu

21.8k total citations · 1 hit paper
28 papers, 1.2k citations indexed

About

Willie Yu is a scholar working on Molecular Biology, Cancer Research and Finance. According to data from OpenAlex, Willie Yu has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 7 papers in Finance. Recurrent topics in Willie Yu's work include Cancer Genomics and Diagnostics (7 papers), Financial Markets and Investment Strategies (6 papers) and Financial Risk and Volatility Modeling (4 papers). Willie Yu is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Financial Markets and Investment Strategies (6 papers) and Financial Risk and Volatility Modeling (4 papers). Willie Yu collaborates with scholars based in Singapore, United States and Taiwan. Willie Yu's co-authors include Steve Rozen, Zura Kakushadze, Bin Tean Teh, Patrick Tan, Song Ling Poon, Arnoud Boot, Alvin Wei Tian Ng, Mi Ni Huang, Xu Qian and Zhimin Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Willie Yu

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia

2017 279 citations Alvin Wei Tian Ng, Song Ling Poon et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Willie Yu Singapore	14	563	368	193	183	167	28	1.2k
Alvin Wei Tian Ng Singapore	10	429 0.8×	330 0.9×	160 0.8×	159 0.9×	102 0.6×	15	1.0k
Sung‐Jig Lim South Korea	24	766 1.4×	310 0.8×	387 2.0×	97 0.5×	199 1.2×	69	1.7k
Madan Lal Brahma Bhatt India	20	556 1.0×	264 0.7×	259 1.3×	95 0.5×	154 0.9×	79	1.1k
Jill E. Kucab United Kingdom	18	913 1.6×	592 1.6×	359 1.9×	153 0.8×	124 0.7×	26	1.7k
Reba Mustafi United States	24	813 1.4×	414 1.1×	366 1.9×	98 0.5×	113 0.7×	45	1.3k
Cedric Chuan Young Ng Singapore	15	317 0.6×	207 0.6×	174 0.9×	140 0.8×	136 0.8×	47	933
Shanming Ruan China	18	628 1.1×	433 1.2×	441 2.3×	172 0.9×	268 1.6×	74	1.4k
Karol L. Thompson United States	24	857 1.5×	228 0.6×	169 0.9×	62 0.3×	95 0.6×	49	1.6k
Jin Y. Jin United States	24	538 1.0×	168 0.5×	732 3.8×	384 2.1×	194 1.2×	95	1.9k
Seungyoon Nam South Korea	24	1.0k 1.9×	538 1.5×	309 1.6×	67 0.4×	214 1.3×	89	1.6k

Countries citing papers authored by Willie Yu

Since Specialization

Citations

This map shows the geographic impact of Willie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willie Yu more than expected).

Fields of papers citing papers by Willie Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willie Yu. The network helps show where Willie Yu may publish in the future.

Co-authorship network of co-authors of Willie Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Willie Yu. A scholar is included among the top collaborators of Willie Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willie Yu. Willie Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chao, Angel, Chen‐Yang Huang, Willie Yu, et al.. (2024). Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma. BMC Cancer. 24(1). 1403–1403. 4 indexed citations

Boot, Arnoud, Mo Liu, Willie Yu, et al.. (2022). Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers. Proceedings of the National Academy of Sciences. 119(4). 27 indexed citations

Boot, Arnoud, Alvin Wei Tian Ng, Fui Teen Chong, et al.. (2020). Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types. Genome Research. 30(6). 803–813. 33 indexed citations

Kakushadze, Zura & Willie Yu. (2019). Altcoin-Bitcoin Arbitrage. SSRN Electronic Journal. 6(1). 87–110. 1 indexed citations

Kakushadze, Zura & Willie Yu. (2019). Machine Learning Risk Models. SSRN Electronic Journal. 2 indexed citations

Huang, Mi, Willie Yu, Maude Ardin, et al.. (2017). Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors. Genome Research. 27(9). 1475–1486. 75 indexed citations

Li, Xinjian, Willie Yu, Xu Qian, et al.. (2017). Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy. Molecular Cell. 66(5). 684–697.e9. 260 indexed citations

Kakushadze, Zura & Willie Yu. (2017). *K-means and cluster models for cancer signatures. SHILAP Revista de lepidopterología. 13. 7–31. 28 indexed citations

Kakushadze, Zura & Willie Yu. (2017). Open Source Fundamental Industry Classification. SSRN Electronic Journal. 1 indexed citations

10.

Kakushadze, Zura & Willie Yu. (2017). *K-Means and Cluster Models for Cancer Signatures. SSRN Electronic Journal. 6 indexed citations

11.

Ng, Alvin Wei Tian, Song Ling Poon, Mi Ni Huang, et al.. (2017). Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Science Translational Medicine. 9(412). 279 indexed citations breakdown →

12.

Kakushadze, Zura & Willie Yu. (2016). How to Combine a Billion Alphas. SSRN Electronic Journal. 2 indexed citations

13.

Poon, Song Ling, Mi Ni Huang, John R. McPherson, et al.. (2015). Mutation signatures implicate aristolochic acid in bladder cancer development. Genome Medicine. 7(1). 38–38. 76 indexed citations

14.

McPherson, John R., Choon Kiat Ong, Cedric Chuan Young Ng, et al.. (2015). Whole‐exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1. Cancer Medicine. 4(12). 1871–1878. 28 indexed citations

15.

Malouf, Gabriel G., Xiaoping Su, Hui Yao, et al.. (2014). Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes. Clinical Cancer Research. 20(15). 4129–4140. 97 indexed citations

16.

Yu, Willie, John R. McPherson, Mark Stevenson, et al.. (2014). Whole-Exome Sequencing Studies of Parathyroid Carcinomas Reveal NovelPRUNE2Mutations, Distinctive Mutational Spectra Related to APOBEC-Catalyzed DNA Mutagenesis and Mutational Enrichment in Kinases Associated With Cell Migration and Invasion. The Journal of Clinical Endocrinology & Metabolism. 100(2). E360–E364. 72 indexed citations

17.

Yu, Willie, Waraporn Chan-on, Melissa C.C. Teo, et al.. (2011). First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum. Genome biology. 12(9). R96–R96. 16 indexed citations

18.

Zang, Zhi Jiang, Choon Kiat Ong, Ioana Cutcutache, et al.. (2010). Genetic and Structural Variation in the Gastric Cancer Kinome Revealed through Targeted Deep Sequencing. Cancer Research. 71(1). 29–39. 69 indexed citations

19.

Yu, Willie & John S. Hill. (2006). Mapping the heparin-binding domain of human hepatic lipase. Biochemical and Biophysical Research Communications. 343(2). 659–665. 13 indexed citations

20.

Yu, Willie, et al.. (2006). Suppression of endothelial or lipoprotein lipase in THP-1 macrophages attenuates proinflammatory cytokine secretion. Journal of Lipid Research. 48(2). 385–394. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact